Porterhouse Medical is 15 years old next month and plans to celebrate delivering on its mission – “Developing a shared vision with our partners to deliver programmes to improve people’s lives” – for a decade and a half.
Last week the mighty Porterhouse Power Athletes took on the new challenge of static wheelchair racing to fundraise for our local charity partners, SportsAble.
Porterhouse Medical, winner of the Queen’s Award for Enterprise, was delighted to welcome Rob Wilson MP to open our new office in Windsor Square this month.
At Porterhouse Medical, we are passionate about the work we do with our partners to help improve people’s lives; which includes using our medical and scientific communications expertise to help raise awareness of disease symptoms and encourage support for relevant charities.
Promising news for patients with Parkinson’s Disease (PD) was reported at the 13th International Conference on Alzheimer’s and Parkinson’s Diseases in Vienna earlier this month. PRX002/RG7935, currently in Phase 1b clinical trials, has been identified as having an acceptable safety profile and is expected to go into phase 2 clinical trials in the next few months.
Porterhouse Medical prides itself on being a company that works together as a family, with humour and happiness instilled in all that we do.
Here, we look at the past to reveal some surprising perceptions about risk factors that are now widely known to be associated with cancer. We also consider how our awareness of risk factors has moved on, so much so that we may have gone too far in the opposite direction…
In order to leverage the wealth of experience that Porterhouse Medical has gathered over the many years of working in a huge range of oncology disease and therapy areas, we have created a new internal department, known as ‘ONCOR’, to focus predominantly on oncology.